High Cholesterol Deteriorates Bone Health: New Insights into Molecular Mechanisms

Area of Science:

• Biomedical Science
• Oncology
• Endocrinology

Background:

• Epidemiological studies link cardiovascular diseases, hyperlipidemia, and hypercholesterolemia to osteoporosis.
• High cholesterol and LDL-cholesterol levels correlate with low bone mineral density, a key osteoporosis predictor.
• High cholesterol is associated with increased cancer risk, and osteoporotic bone may facilitate cancer metastasis.

Purpose of the Study:

• To review how cholesterol and statins influence osteoblast and osteoclast cell function.
• To elucidate molecular mechanisms of cholesterol-mediated bone deterioration.
• To propose how cellular cholesterol promotes cancer-induced bone metastasis.

Main Methods:

• Literature review of epidemiological and basic studies.
• Analysis of molecular mechanisms.
• Synthesis of current research on cholesterol, bone metabolism, and cancer metastasis.

Main Results:

• Cholesterol and statins play a regulatory role in bone cell function, impacting bone density.
• Molecular pathways link cholesterol metabolism to bone health and disease.
• Cellular cholesterol may enhance the bone microenvironment for cancer cell metastasis.

Conclusions:

• Cholesterol dysregulation contributes to osteoporosis and may influence cancer progression.
• Statins' effects on bone cells warrant further investigation in the context of osteoporosis and cancer.
• Understanding cholesterol's role is crucial for developing therapeutic strategies against bone diseases and metastasis.